We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+2.89%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$47.4B
AUM Growth
+$1.55B
(+3.4%)
Cap. Flow
-$454M
Cap. Flow
% of AUM
-0.96%
Top 10 Holdings %
Top 10 Hldgs %
21.97%
Holding
1,164
New
118
Increased
281
Reduced
356
Closed
129
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$485M |
| 2 |
Signet Jewelers
SIG
|
+$418M |
| 3 |
Skyworks Solutions
SWKS
|
+$325M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$324M |
| 5 |
Crown Holdings
CCK
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$321M |
| 2 |
GXP
Great Plains Energy Incorporated
GXP
|
+$299M |
| 3 |
HMHC
Houghton Mifflin Harcourt Company
HMHC
|
+$198M |
| 4 |
Pfizer
PFE
|
+$171M |
| 5 |
K
Kellanova
K
|
+$165M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 15.61% |
| 2 | Healthcare | 15.04% |
| 3 | Technology | 12.55% |
| 4 | Industrials | 12.54% |
| 5 | Financials | 11.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Applied Materials
AMAT
$426B
| $285M | 0.6% |
11,884,006
-3,637,115
| -23% | -$80.2M |
|
52
IQVIA
IQV
$34.7B
| $284M | 0.6% |
4,353,826
-121,281
| -3% | -$8.13M |
|
|
AET
53
DELISTED
Aetna Inc
AET
| $283M | 0.6% |
2,319,415
-87,459
| -4% | -$10M |
|
54
PG&E
PCG
$47.8B
| $277M | 0.58% |
4,330,316
+87,877
| +2% | +$5.26M |
|
55
AB InBev
BUD
$158B
| $273M | 0.58% |
2,070,412
-263,947
| -11% | -$33.2M |
|
|
WBA
56
DELISTED
Walgreens Boots Alliance
WBA
| $271M | 0.57% |
3,259,587
+3,204,795
| +5,849% | +$259M |
|
57
SLB Ltd
SLB
$77.8B
| $271M | 0.57% |
3,424,285
+437,441
| +15% | +$33.5M |
|
58
EOG Resources
EOG
$78B
| $262M | 0.55% |
3,134,901
+38,403
| +1% | +$3.08M |
|
59
Chevron
CVX
$388B
| $259M | 0.55% |
2,467,648
+167,176
| +7% | +$16.8M |
|
|
GWR
60
DELISTED
Genesee & Wyoming Inc.
GWR
| $255M | 0.54% |
4,319,230
+1,553,430
| +56% | +$95.1M |
|
|
SCHW
61
Charles Schwab
SCHW
$177B
| $241M | 0.51% |
9,510,168
-228,691
| -2% | -$6.5M |
|
62
Hartford Financial Services
HIG
$38.5B
| $233M | 0.49% |
5,253,190
+32,712
| +0.6% | +$1.46M |
|
63
Ameren
AEE
$31.5B
| $230M | 0.48% |
4,284,358
-313,212
| -7% | -$15.4M |
|
64
Thermo Fisher Scientific
TMO
$211B
| $224M | 0.47% |
1,515,894
-272,116
| -15% | -$40.2M |
|
65
Norwegian Cruise Line
NCLH
$8.89B
| $219M | 0.46% |
5,489,282
-2,459,743
| -31% | -$117M |
|
66
Ryanair
RYAAY
$29.5B
| $214M | 0.45% |
7,680,920
+1,886,090
| +33% | +$61.2M |
|
67
Fidelity National Information Services
FIS
$21.5B
| $201M | 0.42% |
2,733,322
-2,207,132
| -45% | -$155M |
|
|
SHPG
68
DELISTED
Shire pic
SHPG
| $192M | 0.41% |
1,043,606
-79,453
| -7% | -$14.3M |
|
|
PXD
69
DELISTED
Pioneer Natural Resource Co.
PXD
| $192M | 0.4% |
1,266,917
-295,756
| -19% | -$46.4M |
|
70
Novartis
NVS
$295B
| $187M | 0.4% |
2,535,380
+37,201
| +1% | +$2.57M |
|
71
Intuitive Surgical
ISRG
$121B
| $182M | 0.38% |
2,478,600
+294,300
| +13% | +$20.7M |
|
72
Bristol-Myers Squibb
BMY
$127B
| $181M | 0.38% |
2,455,102
-194,721
| -7% | -$13.8M |
|
73
British American Tobacco
BTI
$132B
| $180M | 0.38% |
2,773,736
+69,940
| +3% | +$4.24M |
|
74
Deckers Outdoor
DECK
$13.3B
| $166M | 0.35% |
17,288,010
-1,751,844
| -9% | -$16.2M |
|
|
MNK
75
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $162M | 0.34% |
2,667,364
-219,591
| -8% | -$13.4M |
|
Similar funds
QCM
Lazard Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, Lazard Asset Management held 1,164 positions worth $47.4B, up 3.4% from $45.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Lazard Asset Management's Q2 2016 filing shows 118 new, 281 increased, 356 reduced and 129 closed positions. Its largest new stake was Crown Holdings: 5,754,541 shares worth $292M. The largest sale was Apple, an estimated $321M.
By sector, the portfolio is most concentrated in Communication Services at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- Lazard Asset Management's largest Q2 2016 buy was Crown Holdings: 5,754,541 shares worth $292M.
- Lazard Asset Management added most to Allergan plc in Q2 2016, an estimated $485M increase.
- Lazard Asset Management's biggest Q2 2016 reduction was Apple, cutting an estimated $321M.
- Lazard Asset Management fully exited APA Corp in Q2 2016, selling an estimated $65M.
- Lazard Asset Management's ten largest holdings make up 22% of its $47.4B portfolio in Q2 2016.
- Lazard Asset Management opened 118 new positions and closed 129 in Q2 2016.
- Lazard Asset Management's portfolio value rose 3.4% quarter-over-quarter to $47.4B.
Based on Lazard Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.